`
`
`
`Filed: September 29, 2017
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`_____________________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_____________________________
`
`
`
`MYLAN PHARMACEUTICALS INC., TEVA PHARMACEUTICALS USA,
`INC. and AKORN INC.,1
`Petitioner,
`
`v.
`
`ALLERGAN, INC.
`Patent Owner.
`
`_____________________________
`
`Case IPR2016-01127 (US 8,685,930 B2)
`Case IPR2016-01128 (US 8,629,111 B2)
`Case IPR2016-01129 (US 8,642,556 B2)
`Case IPR2016-01130 (US 8,633,162 B2)
`Case IPR2016-01131 (US 8,648,048 B2)
`Case IPR2016-01132 (US 9,248,191 B2)
`_____________________________
`
`PETITIONERS’ NOTICE OF OBJECTION TO EVIDENCE
`
`
`1 Cases IPR2017-00576 and IPR2017-00594, IPR2017-00578 and IPR2017-
`00596, IPR2017-00579 and IPR2017-00598, IPR2017-00583 and IPR2017-00599,
`IPR2017-00585 and IPR2017-00600, and IPR2017-00586 and IPR2017-00601,
`have respectively been joined with the captioned proceedings. The word-for-word
`identical paper is filed in each proceeding identified in the caption pursuant to the
`Board’s Scheduling Order (Paper 10).
`
`
`
`
`
`
`
`
`
`I.
`II.
`
`TABLE OF CONTENTS
`
`Objections to EX2100, EX2101, EX2102, and any
`
`INTRODUCTION ........................................................................................ 1
`OBJECTIONS .............................................................................................. 1
`1.
`Reference to/Reliance Thereon ................................................. 1
`2.
`Reference to/Reliance Thereon ................................................. 2
`3.
`Thereon ..................................................................................... 3
`III. CONCLUSION ............................................................................................ 3
`
`Objections to EX2086, EX2087 and EX2103, and any
`
`Objections to URLs, and any Reference to/Reliance
`
`
`
`
`-i-
`
`
`
`
`
`I.
`
`INTRODUCTION
`
`Pursuant to 37 C.F.R. § 42.64(b)(1), Petitioners submit the following
`
`objections to Exhibits 2086, 2087 and 2100-2103 as listed on each List of Exhibits
`
`filed by the St. Regis Mohawk Tribe (“SRMT”) and two unlisted URLs in its
`
`motion to dismiss (“Motion”), and any reference to or reliance on the foregoing
`
`Exhibits in SRMT filings. As required by 37 C.F.R. §42.62, Petitioners’ objections
`
`below apply the Federal Rules of Evidence (“F.R.E.”).
`
`II. OBJECTIONS
`1. Objections to EX2100, EX2101, EX2102, and any Reference
`to/Reliance Thereon
`
`Grounds for Objection: F.R.E. 402 (Relevance); 403 (Prejudice); 801, 802,
`
`803, 805 (Inadmissible Hearsay).
`
`SRMT describes EX2100 as “National Congress of American Indians,
`
`Current Tax Needs in Indian Country”; EX2101 as “National Congress of
`
`American Indians, Securing Our Futures”; and EX2102 as “National Congress of
`
`American Indians, Taxation”.
`
`SRMT relies on these exhibits to provide critiques of the impacts of Federal
`
`taxation and development policies on Tribes. The Board has no power to address
`
`these policies, any remedy must come from Congress. The exhibits have no
`
`relevance to patent law or to any issue properly before the Board for decision.
`
`Instead, SRMT provides the exhibits to evoke sympathy. Assuming arguendo the
`
`
`-1-
`
`
`
`truth of the statements in the exhibits and the justification of the critiques,
`
`sympathy for SRMT or Tribes generally is not a basis for dismissal under
`
`chapter 31 of the Patent Code (35 U.S.C.). EX2100, EX2101 and EX2102 are
`
`inadmissible under F.R.E. 402 and under F.R.E. 403.
`
`Additionally, these exhibits are not testimony, yet SRMT relies on their
`
`statements to prove the truth of the matter asserted. These exhibits are thus used to
`
`provide hearsay statements without exception. To the extent SRMT relies on
`
`EX2100, EX2101 and EX2102, or on any statements in them for the truth of the
`
`matter asserted, such statements are inadmissible hearsay. F.R.E. 801, 802, 803,
`
`805.
`
`2. Objections to EX2086, EX2087 and EX2103, and any
`Reference to/Reliance Thereon
`
`Grounds for Objection: F.R.E. 106 (Incomplete Writing).
`
`SRMT describes EX2086 as an “Assignment Agreement (Long form)”;
`
`EX2087 as a “Patent License Agreement”; and EX2103 as a recorded assignment
`
`of the involved patents.
`
`Each of these exhibits individually, and all three in combination, is an
`
`incomplete representation of the totality of transactions between SRMT and
`
`Allergan affecting the involved patents. In fairness, all of the documents reflecting
`
`the scope and nature of the transactions between SRMT and Allergan affecting the
`
`involved patents must be considered together. F.R.E. 106.
`
`-2-
`
`
`
`3. Objections to URLs, and any Reference to/Reliance Thereon
`
`Grounds for Objection: F.R.E. 802 (Inadmissible Hearsay).
`
`In the Motion, SRMT cites two URLs without providing corresponding
`
`exhibits: https://www.srmt-nsn.gov/about-the-tribe and https://www.srmt-
`
`nsn.gov/economic-development.
`
`To the extent SRMT relies on these URLs or on any statements in these
`
`URLs for the truth of the matter asserted, such statements are inadmissible hearsay.
`
`F.R.E. 801, 802, 803, 805.
`
`
`III. CONCLUSION
`
`The aforementioned exhibits and URLs are not admissible for the reasons
`
`stated above.
`
`
`
`Dated: September 29, 2017
`
`
`
`
`
`
`
`Respectfully submitted,
`
`/ Steven W. Parmelee /
` Steven W. Parmelee
` Reg. No. 31,990
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`-3-
`
`
`
`CERTIFICATE OF SERVICE
`
`
`
`This is to certify that I caused to be served a true and correct copy of the
`
`foregoing Petitioners’ Notice of Objection to Evidence, on this 29th day of
`
`September, 2017, on Allergan and St. Regis Mohawk Tribe at the correspondence
`
`address of Allergan and St. Regis Mohawk Tribe as follows:
`
`Dorothy P. Whelan
`Michael Kane
`Susan Morrison Colletti
`Robert M. Oakes
`Jonathan Singer
`Fish & Richardson P.C.
`3200 RBC Plaza
`60 South Sixth Street
`Minneapolis, MN 55402
`Email: IPR13351-0008IP1@fr.com
`Email: IPR13351-0008IP2@fr.com
`Email: IPR13351-0008IP3@fr.com
`Email: IPR13351-0008IP4@fr.com
`Email: IPR13351-0008IP5@fr.com
`Email: IPR13351-0008IP6@fr.com
`Email: PTABInbound@fr.com
`
`
`Alfonso Chan
`Joseph DePumpo
`Michael W. Shore
`Christopher L. Evans
`Shore Chan DePumpo LLP
`901 Main Street, Suite 3300
`Dallas, TX 75201
`Email: achan@shorechan.com
`Email: jdepumpo@shorechan.com
`Email: mshore@shorechan.com
`Email: cevans@shorechan.com
`
`
`-4-
`
`
`
`Marsha K. Schmidt
`14928 Perrywood Drive
`Burtonsville, MD 20866
`Email: marsha@mkschmidtlaw.com
`
`And on the remaining petitioners as follows:
`
`
`Gary Speier
`Mark Schuman
`CARLSON, CASPERS, VANDENBURGH,
`LINDQUIST & SCHUMAN, P.A.
`225 South Sixth Street, Suite 4200
`Minneapolis, MN 55402
`Email: gspeier@carlsoncaspers.com
`Email: mschuman@carlsoncaspers.com
`Attorneys for Teva Pharmaceuticals USA, Inc.
`
`
`Michael Dzwonczyk
`Azadeh Kokabi
`Travis Ribar
`SUGHRUE MION, PLLC
`2100 Pennsylvania Ave., NW
`Washington, DC 20037
`Email: mdzwonczyk@sughrue.com
`Email: akokabi@sughrue.com
`Email: tribar@sughrue.com
`Attorneys for Akorn Inc.
`
`
`
`Dated: September 29, 2017
`
`
`
`
`
`
`Respectfully submitted,
`
`/ Steven W. Parmelee /
` Steven W. Parmelee, Lead Counsel
` Reg. No. 31,990
`
`
`
`
`
`-5-
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
